title: Adenovirus: current epidemiology and emerging approaches to prevention and treatment.
abstract: Infections caused by adenoviruses are associated with significant morbidity and mortality in both hematopoietic stem cell and solid organ transplant recipients. The risk seems to be highest in allogeneic hematopoietic stem cell transplant recipients as well as heart, lung and small-bowel transplant recipients. Management of these infections may be difficult and includes reduction of immunosuppression whenever possible combined sometimes with antiviral therapy (mainly cidofovir). The currently available antiviral therapy is limited by the need for intravenous administration, potentially significant renal and hematologic toxicities. New emerging therapies such as brincidofovir and transfusion of adenovirus-specific T-lymphocytes may increase the available armamentarium for these potentially life-threatening infections.
authors.affiliation: Division of Infectious Diseases, Transplant Infectious Diseases Program, University of Nebraska Medical Center, Omaha, NE, USA.
authors.forename: Uriel
authors.initials: U
authors.lastname: Sandkovsky
authors.forename: Luciano
authors.initials: L
authors.lastname: Vargas
authors.forename: Diana F
authors.initials: DF
authors.lastname: Florescu